CPT® Code 81325

PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; full sequence analysis

The CPT® Code 81325 refers to the full sequence analysis of the PMP22 (peripheral myelin protein 22) gene, which is crucial for diagnosing conditions such as Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. This molecular genetic testing aims to identify specific mutations within the PMP22 gene located on chromosome 17. The PMP22 gene encodes a protein that is an essential component of the myelin sheath surrounding nerve cells, which is vital for the proper transmission of nerve impulses. The protein is produced by Schwann cells, which are responsible for the formation and maintenance of the myelin sheath. Mutations in the PMP22 gene can lead to various forms of neuropathy, with inheritance patterns that may be autosomal recessive or autosomal dominant. In the case of autosomal recessive inheritance, an individual must inherit a mutated gene from both parents to exhibit symptoms of the disease. Conversely, in autosomal dominant inheritance, only one copy of the mutated gene is sufficient to cause the disorder. The most prevalent form of Charcot-Marie-Tooth disease, known as Type 1A, is characterized by a duplication of the PMP22 gene, resulting in an overproduction of the PMP22 protein. This overproduction disrupts the normal processing of the protein, leading to a reduction in functional PMP22 levels, which in turn decreases myelin integrity and impairs nerve function. Additionally, hereditary neuropathy with liability to pressure palsies is often associated with a reduction in gene dosage, where one copy of the PMP22 gene is lost, leading to insufficient levels of the protein. This condition can also arise from mutations that produce a smaller, unstable version of the PMP22 protein, which degrades rapidly and fails to protect the myelin sheath, making it more susceptible to damage from pressure. The full sequence analysis provided by CPT® Code 81325 is essential for identifying these mutations, thereby facilitating accurate diagnosis and management of these hereditary neuropathies.